We surveyed 50 senior strategy leaders to understand their genAI implementation tactics — and why some teams are seeing better results than others.
With industry leaders divided in their approaches, we look at the winners and losers in the open-source vs. closed-source landscape and what enterprises need to think about next for adoption.
In this webinar, our expert explores how leading enterprises are integrating genAI into their strategies to drive results and stay ahead of the competition.
We highlight notable generative AI deals, partnerships, and big tech activity in December 2024.
From AI’s banner year to an 8-year low in global dealmaking, we break down key changes in the venture landscape using CB Insights data.
AI promises to accelerate the path from bench to bedside. Using CB Insights data, we highlight emerging markets in the preclinical phase that are ripe for pharma investments and partnerships.
We map out 60+ companies developing AI agents & copilots for industrial applications, including manufacturing, logistics, semiconductors, defense, and construction.
We analyze funding and acquisitions data, clinical progress, and partnership strategies to help pharma companies and investors navigate the maturing AI landscape in drug discovery.
We highlight notable generative AI deals, partnerships, and big tech activity in November 2024.
We examine what’s driving recent investment, partnership, and exit activity in the autonomous driving space to identify leaders and determine the market's direction.
Discover the key trends our experts anticipate will shape the tech landscape in 2025.
The future of LLMs. Caregiving humanoid robots. Crypto’s baby steps. We use CB Insights data to uncover 15 emerging trends that will shape the tech landscape for years to come.
From in-home humanoids to autonomous labs, we highlight the growing opportunities in robotics markets for providers and other healthcare stakeholders.
We use CB Insights data to break down the AI trends highlighted at the conference that insurers should watch to stay ahead of competitors.
Dive into the latest AI activity, and discover the emerging trends our data is signaling.
We mined the CB Insights database to map 55 generative AI companies that sell to financial institutions and support key financial workflows.
We highlight notable generative AI deals, partnerships, and big tech activity in October 2024.
AI is helping extend retailers’ digital advertising networks’ reach across hyper-personalized content and new search platforms. We highlight opportunities for retailers, brands, ad agencies, and other industry stakeholders.
We mined Mayo Clinic’s investments to determine how AI is shaping the next generation of healthcare.
Our panel of experts discuss the emerging technologies set to transform the way we live, work, and connect.
Quarterly AI deal count spikes to reach highest level since Q1’22 peak.
From virtual training simulators to vehicle path forecasting, we look at how generative AI is bringing vehicles closer to full automation and highlight opportunities for automakers, car insurers, and other industry stakeholders.
We examine the near- and long-term implications of Uber’s activity in autonomous vehicles across its main business lines.
GenAI tools are moving deeper into e-commerce operations, with emerging applications in packaging design, UX optimization, supply chain management, and more. We map out tech startup activity across the ecosystem.
We highlight emerging opportunities for generative AI — from AI agents to digital twins to small language models — across the insurance value chain.